Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30010084HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30077045HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30082748HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30081135HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30084147HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30085083HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30078680HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30024468HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30024469HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS30024470HIVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TCGA Plot Options
Drug Information
GeneDPYD
DrugBank IDDB03516
Drug NameEniluracil
Target IDBE0000960
UniProt IDQ12882
Regulation Type
PubMed IDs16466986
CitationsCzito BG, Hong TJ, Cohen DP, Petros WP, Tyler DS, Pappas TN, Yu D, Lee CG, Lockhart AC, Morse MA, Fernando N, Hurwitz HI: A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract. Cancer Invest. 2006 Feb;24(1):9-17.
GroupsInvestigational
Direct ClassificationPyrimidones
SMILESO=C1NC=C(C#C)C(=O)N1
Pathways
PharmGKB
ChEMBLCHEMBL355200